SkinHealth Systems SKIN
NASDAQ SKIN
$0.70 -0.04 (-5.03%)
As of: Sep 9, 2026 · 11:27 AM EDT

SkinHealth Systems (SKIN) Liabilities and Shareholders Equity (2020 - 2026)

SkinHealth Systems' (SKIN) quarterly Liabilities and Shareholders Equity came in at $486.6 million in Q2 2026, down 4.14% year-over-year from $507.6 million in Q2 2025, and up 2.82% quarter-over-quarter from $473.2 million in Q1 2026.

Analysis

SkinHealth Systems (SKIN) Liabilities and Shareholders Equity (2020 - 2026) Analysis & Trends

SkinHealth Systems (SKIN) has reported Liabilities and Shareholders Equity for 7 consecutive years, with $486.6 million the latest figure, recorded in Q2 2026.

  • On a quarterly basis, Liabilities and Shareholders Equity fell 4.14% year-over-year to $486.6 million in Q2 2026; TTM through Jun 2026 was $2.0 billion, a 23.51% decrease from a year earlier, with the FY2025 full-year figure at $499.8 million, down 27.11% from the prior year.
  • Liabilities and Shareholders Equity was $486.6 million for Q2 2026 at SkinHealth Systems, up from $473.2 million in the prior quarter.
  • Over five years, Liabilities and Shareholders Equity peaked at $1.2 billion in Q2 2022 and troughed at $473.2 million in Q1 2026.
  • A 5-year average of $806.3 million and a median of $778.3 million in 2024 frame the typical range for Liabilities and Shareholders Equity.
  • Across the five-year window, Liabilities and Shareholders Equity jumped 254.72% in 2022 and dropped 29.77% in 2026, its largest moves.
  • Over 5 years, Liabilities and Shareholders Equity stood at $1.0 billion in 2022, then dropped by 7.37% to $929.1 million in 2023, then dropped by 26.2% to $685.7 million in 2024, then dropped by 27.11% to $499.8 million in 2025, then fell by 2.65% to $486.6 million in 2026.
  • The last three Liabilities and Shareholders Equity figures came in at $486.6 million (Q2 2026), $473.2 million (Q1 2026), and $499.8 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Abbott Laboratories 185.27 Bn 179.67 Bn 7.27 Bn 109.22 Bn
2 Intuitive Surgical 124.48 Bn 119.26 Bn 1.96 Bn 20.88 Bn
3 Medtronic 118.49 Bn 109.67 Bn 6.34 Bn 93.31 Bn
4 Stryker 105.21 Bn 101.74 Bn 4.50 Bn 47.93 Bn
5 Boston Scientific 66.93 Bn 66.39 Bn 3.85 Bn 45.22 Bn
6 Edwards Lifesciences 49.85 Bn 45.60 Bn 1.35 Bn 13.87 Bn
7 Alcon 33.99 Bn 32.53 Bn 1.68 Bn 31.10 Bn
8 Dexcom 32.32 Bn 30.38 Bn 830.00 Mn 6.46 Bn
9 Steris 21.14 Bn 20.66 Bn 684.20 Mn 10.74 Bn
10 SkinHealth Systems 92.04 Mn -114.03 Mn 49.34 Mn 486.57 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 486.57 Mn
Mar 31, 2026 473.23 Mn
Dec 31, 2025 499.80 Mn
Sep 30, 2025 503.64 Mn
Jun 30, 2025 507.57 Mn
Mar 31, 2025 673.82 Mn
Dec 31, 2024 685.68 Mn
Sep 30, 2024 699.55 Mn
Jun 30, 2024 711.83 Mn
Mar 31, 2024 844.74 Mn
Dec 31, 2023 929.11 Mn
Sep 30, 2023 973.07 Mn
Jun 30, 2023 1.01 Bn
Mar 31, 2023 994.95 Mn
Dec 31, 2022 1.00 Bn
Sep 30, 2022 1.10 Bn
Jun 30, 2022 1.21 Bn
Mar 31, 2022 1.20 Bn
Dec 31, 2021 1.22 Bn
Sep 30, 2021 997.88 Mn